Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Xigang Leng"'
Autor:
Bo Deng, Bing Ma, Yingying Ma, Pei Cao, Xigang Leng, Pengyu Huang, Yuanyuan Zhao, Tianjiao Ji, Xueguang Lu, Lanxia Liu
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Chemotherapeutics that can trigger immunogenic cell death (ICD) and release tumor-specific antigens are effective on treating a variety of cancers. The codelivery of chemotherapeutics with adjuvants is a promising strategy to achieve synergi
Externí odkaz:
https://doaj.org/article/2c883afa910c405bac4fae936fbb2856
Autor:
Binhan Li, Huimin Jing, Zhiting Sun, Xiaoxiao Wang, Deling Kong, Jing Liu, Xigang Leng, Zhihong Wang
Publikováno v:
Smart Materials in Medicine, Vol 2, Iss , Pp 209-218 (2021)
Calcification-caused failure and deterioration have become the biggest issues facing traditional biological heart valves (BHVs). Thus, developing new source of materials with the ability to resist calcification is an imperative demand of clinical. In
Externí odkaz:
https://doaj.org/article/e87188e1c41c49fc80c94e6bb316388f
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 143-151 (2017)
Monitoring drug release and therapeutic efficacy is crucial for developing drug delivery systems. Our preliminary study demonstrated that, as compared with pristine multiwalled carbon nanotubes (MWCNTs), transactivator of transcription (TAT)-chitosan
Externí odkaz:
https://doaj.org/article/d092401a1e8747e8b2e351b4e68c481b
Publikováno v:
International Journal of Nanomedicine, Vol 2010, Iss default, Pp 1095-1102 (2010)
Dunwan Zhu1*, Xu Jin2*, Xigang Leng1, Hai Wang1, Junbo Bao1, Wenguang Liu3, Kangde Yao3, Cunxian Song11Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical C
Externí odkaz:
https://doaj.org/article/cb4879f8453c4029a4602010b61f110b
Publikováno v:
International Journal of Nanomedicine.
Ying Yang,1 Ning Wang,2 XinXin Tian,1 XiaoLi Wang,1 Jing Yang,1 XiGang Leng,1 HaiLing Zhang1 1Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Biomaterials, Tianjin, Pe
Autor:
Deling Kong, Xigang Leng, Jing Liu, Binhan Li, Xiaoxiao Wang, Zhihong Wang, Zhiting Sun, Huimin Jing
Publikováno v:
Smart Materials in Medicine. 2:209-218
Calcification-caused failure and deterioration have become the biggest issues facing traditional biological heart valves (BHVs). Thus, developing new source of materials with the ability to resist calcification is an imperative demand of clinical. In
Autor:
Zhiting Sun, Jing Liu, Binhan Li, Huimin Jing, Xigang Leng, Zhihong Wang, Xiaoxiao Wang, Deling Kong
Publikováno v:
ACS Applied Bio Materials. 3:2275-2283
Glutaraldehyde (GA) was conventionally used to crosslink bovine pericardium to prepare bioprosthetic heart valves (BHVs), which usually fail within 10 years because of valve deterioration and calcification. To overcome the high cytotoxicity and sever
Publikováno v:
Biomaterials Science. 8:4757-4766
Combined blockades of CTLA-4 and PD-1 can yield better overall complementary clinical outcomes than individual blockades, but the response rates are still relatively low. To investigate the anti-tumor effects of various combined strategies, we design
Autor:
Tianjiao Ji, Pei Cao, Xueguang Lu, Bo Deng, Bing Ma, Lanxia Liu, Yingying Ma, Xigang Leng, Pengyu Huang
Background: Cancer nanovaccine has become a promising approach for cancer immunotherapy. The major challenge of cancer vaccines is limited efficacy caused by lack of desirable tumor specific antigens (TSA). Chemotherapeutics can trigger immunogenic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba418dac5480a198a86924de976b9ea5
https://doi.org/10.21203/rs.3.rs-1074689/v1
https://doi.org/10.21203/rs.3.rs-1074689/v1
Autor:
Bo Deng, Bing Ma, Yingying Ma, Pei Cao, Xigang Leng, Pengyu Huang, Yuanyuan Zhao, Tianjiao Ji, Xueguang Lu, Lanxia Liu
Publikováno v:
Journal of nanobiotechnology. 20(1)
Chemotherapeutics that can trigger immunogenic cell death (ICD) and release tumor-specific antigens are effective on treating a variety of cancers. The codelivery of chemotherapeutics with adjuvants is a promising strategy to achieve synergistic ther